Abiopharma

🔍 Edmonds-Waters Christopher (Executive)

Company: HERITAGE COMMERCE CORP (HTBK)

Report Date: 2026-04-17

Detailed Transactions and Holdings:

• Sold 9,639 shares of Common Stock, No Par Value (Direct)
  Date: 2026-04-17 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 42,099 shares of Restricted Stock Unit (Derivative)
  Date: 2026-04-17 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F2
• Sold 8,898 shares of Performance-Based Restricted Stock Unit (Derivative)
  Date: 2026-04-17 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: On April 17, 2026 (the "Effective Time"), upon consummation of the transactions contemplated by the Agreement and Plan of Reorganization and Merger (the "Merger Agreement"), dated as of December 17, 2025, by and between Heritage Commerce Corp (the "Company"), a California corporation and CVB Financial Corp. ("CVBF"), a California corporation, and subject to the terms and conditions set forth in the Merger Agreement, each share of the Company's common stock outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive 0.65 shares (the "Exchange Ratio") of CVBF's common stock, without interest thereon (the "Merger Consideration").
• F2: At the Effective Time, each outstanding restricted stock unit award became vested by its terms on the closing date and was converted into a right to receive a number of shares of CVBF common stock equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Company common stock subject to such restricted stock unit award immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, less applicable taxes.